Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

301 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cannabidiol monotherapy for treatment-resistant schizophrenia.
Zuardi AW, Hallak JE, Dursun SM, Morais SL, Sanches RF, Musty RE, Crippa JA. Zuardi AW, et al. Among authors: crippa ja. J Psychopharmacol. 2006 Sep;20(5):683-6. doi: 10.1177/0269881106060967. Epub 2006 Jan 9. J Psychopharmacol. 2006. PMID: 16401651 Clinical Trial.
The psychiatric side-effects of rimonabant.
Moreira FA, Crippa JA. Moreira FA, et al. Among authors: crippa ja. Braz J Psychiatry. 2009 Jun;31(2):145-53. doi: 10.1590/s1516-44462009000200012. Braz J Psychiatry. 2009. PMID: 19578688 Review.
Neuroimaging in social anxiety disorder: a systematic review of the literature.
Freitas-Ferrari MC, Hallak JE, Trzesniak C, Filho AS, Machado-de-Sousa JP, Chagas MH, Nardi AE, Crippa JA. Freitas-Ferrari MC, et al. Among authors: crippa ja. Prog Neuropsychopharmacol Biol Psychiatry. 2010 May 30;34(4):565-80. doi: 10.1016/j.pnpbp.2010.02.028. Epub 2010 Mar 4. Prog Neuropsychopharmacol Biol Psychiatry. 2010. PMID: 20206659 Review.
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report.
Crippa JA, Derenusson GN, Ferrari TB, Wichert-Ana L, Duran FL, Martin-Santos R, Simões MV, Bhattacharyya S, Fusar-Poli P, Atakan Z, Santos Filho A, Freitas-Ferrari MC, McGuire PK, Zuardi AW, Busatto GF, Hallak JE. Crippa JA, et al. J Psychopharmacol. 2011 Jan;25(1):121-30. doi: 10.1177/0269881110379283. Epub 2010 Sep 9. J Psychopharmacol. 2011. PMID: 20829306 Clinical Trial.
Adhesio interthalamica alterations in schizophrenia spectrum disorders: A systematic review and meta-analysis.
Trzesniak C, Kempton MJ, Busatto GF, de Oliveira IR, Galvão-de Almeida A, Kambeitz J, Ferrari MC, Filho AS, Chagas MH, Zuardi AW, Hallak JE, McGuire PK, Crippa JA. Trzesniak C, et al. Among authors: crippa ja. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):877-86. doi: 10.1016/j.pnpbp.2010.12.024. Epub 2011 Feb 16. Prog Neuropsychopharmacol Biol Psychiatry. 2011. PMID: 21300129 Review.
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients.
Bergamaschi MM, Queiroz RH, Chagas MH, de Oliveira DC, De Martinis BS, Kapczinski F, Quevedo J, Roesler R, Schröder N, Nardi AE, Martín-Santos R, Hallak JE, Zuardi AW, Crippa JA. Bergamaschi MM, et al. Among authors: crippa ja. Neuropsychopharmacology. 2011 May;36(6):1219-26. doi: 10.1038/npp.2011.6. Epub 2011 Feb 9. Neuropsychopharmacology. 2011. PMID: 21307846 Free PMC article. Clinical Trial.
Anti-aversive effects of cannabidiol on innate fear-induced behaviors evoked by an ethological model of panic attacks based on a prey vs the wild snake Epicrates cenchria crassus confrontation paradigm.
Uribe-Mariño A, Francisco A, Castiblanco-Urbina MA, Twardowschy A, Salgado-Rohner CJ, Crippa JA, Hallak JE, Zuardi AW, Coimbra NC. Uribe-Mariño A, et al. Among authors: crippa ja. Neuropsychopharmacology. 2012 Jan;37(2):412-21. doi: 10.1038/npp.2011.188. Epub 2011 Sep 14. Neuropsychopharmacology. 2012. PMID: 21918503 Free PMC article.
301 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page